Access
Waiting time and gestation at treatment were used to assess how the two models impacted access. Waiting time was defined as the interval from first contact with the abortion provider to when medication was dispensed (either in-person in clinic or posted). Gestation was recorded as that applicable on the date mifepristone was dispensed or provided. Analysis was of mean gestation and the proportion of abortions performed at ≤6 weeks’ gestation.